RoylanceR, GormanP, HarrisW. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res.1999; 59: 1433–1436.
2.
LakhaniSR. The transition from hyperplasia to invasive carcinoma of the breast. J Pathol.1999; 187: 272–278.
3.
BuergerH, BockerW. New insights into the pathogenesis of in situ carcinomas of the breast by means of comparative genomic hybridization. In: SilversteinM, ed. Ductal Carcinoma In Situ of the Breast.2nd ed.Philadelphia, PA: Lippincott Williams & Wilkins;2002: 67–76.
4.
Reis-FilhoJS, LakhaniSR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res.2003; 5: 313–319.
5.
SimpsonPT, Reis-FilhoJS, GaleT, LakhaniSR. Molecular evolution of breast cancer. J Pathol.2005; 205: 248–254.
6.
MoulisS, SgroiDC. Re-evaluating early breast neoplasia. Breast Cancer Res.2008; 10: 302.
7.
KimJB, SteinR, O'HareMJ. Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis. Tumour Biol.2005; 26: 173–185.
8.
MickeP, OstmanA. Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy. Expert Opin Ther Targets.2005; 9: 1217–1233.
9.
Ronnov-JessenL, BissellMJ. Breast cancer by proxy: can the microenvironment be both the cause and consequence?Trends Mol Med.2009; 15: 5–13.
10.
PorterD, Lahti-DomeniciJ, KeshaviahA. Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res.2003; 1: 362–375.
11.
MaXJ, SalungaR, TuggleJT. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A.2003; 100: 5974–5979.
12.
LakhaniSR, O'HareMJ. The mammary myoepithelial cell- Cinderella or ugly sister?Breast Cancer Res.2001; 3: 1–4.
13.
BarskySH, KarlinNJ. Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell. Nat Clin Pract Oncol.2006; 3: 138–151.
14.
PolyakK, HuM. Do myoepithelial cells hold the key for breast tumor progression?J Mammary Gland Biol Neoplasia.2005; 10: 231–247.
15.
AllinenM, BeroukhimR, CaiL. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell.2004; 6: 17–32.
16.
AdrianceMC, InmanJL, PetersenOW, BissellMJ. Myoepi-thelial cells: good fences make good neighbors. Breast Cancer Res.2005; 7: 190–197.
17.
HuM, YaoJ, CaiL. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet.2005; 37: 899–905.
18.
HilsonJB, SchnittSJ, CollinsLC. Phenotypic alterations in ductal carcinoma in situ associated myoepithelial cells: biologic and diagnostic implications. Am J Surg Pathol.2009; 33: 227–232.
19.
ToussaintJ, DurbecqV, Haibe-KainsB. Decreased CD10 expression is associated with a higher risk of relapse in ductal carcinoma in situ (DCIS). Cancer Res.2009; 69(Suppl):629.
20.
ChangHY, NuytenDS, SneddonJB. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A.2005; 102: 3738–3743.
21.
WitkiewiczAK, DasguptaA, SotgiaF. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol.2009; 174: 2023–2034.
22.
GuidiAJ, FischerL, HarrisJR, SchnittSJ. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst.1994; 86: 614–619.
23.
JacobsTW, SchnittSJ, TanX, BrownLF. Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation. Hum Pathol.2002; 33: 29–38.
24.
BrownLF, GuidiAJ, SchnittSJ. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res.1999; 5: 1041–1056.
25.
KleerCG, Bloushtain-QimronN, ChenYH. Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Clin Cancer Res.2008; 14: 5357–5367.
26.
WitkiewiczAK, DasguptaA, NguyenKH. Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer. Cancer Biol Ther.2009; 8: 1071–1079.
27.
BoydNF, GuoH, MartinLJ. Mammographic density and the risk and detection of breast cancer. N Engl J Med.2007; 356: 227–236.
28.
GuoYP, MartinLJ, HannaW. Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev.2001; 10: 243–248.
29.
WangY, ConnollyJ, HuR. Expression of insulin-like growth factor-I receptor (IGF-IR) in normal breast tissue and breast cancer risk: results from the Nurses, Health Study. Mod Pathol.2009; 22(Suppl 1):73A.
30.
RomanelliRJ, LeBeauAP, FulmerCG, LazzarinoDA, HochbergA, WoodTL. Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphory-lation of Akt. J Biol Chem.2007; 282: 22513–22524.
